Humana Inc. (NYSE:HUM) Shares Sold by Socorro Asset Management LP

Socorro Asset Management LP lowered its position in shares of Humana Inc. (NYSE:HUM) by 31.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,460 shares of the insurance provider’s stock after selling 5,315 shares during the period. Socorro Asset Management LP’s holdings in Humana were worth $3,630,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Ontario Teachers Pension Plan Board boosted its position in shares of Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after acquiring an additional 71,910 shares in the last quarter. Swedbank AB boosted its holdings in Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after purchasing an additional 3,085 shares in the last quarter. Heritage Oak Wealth Advisors LLC purchased a new position in Humana in the second quarter valued at approximately $3,456,000. Charles Schwab Investment Management Inc. raised its holdings in Humana by 3.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider’s stock worth $284,810,000 after purchasing an additional 26,056 shares in the last quarter. Finally, Mandatum Life Insurance Co Ltd lifted its position in shares of Humana by 115.4% during the 3rd quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock worth $4,434,000 after buying an additional 7,500 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $296.38 on Friday. The firm’s fifty day simple moving average is $275.33 and its 200-day simple moving average is $329.36. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $35.69 billion, a PE ratio of 26.25, a price-to-earnings-growth ratio of 2.34 and a beta of 0.52. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $504.79.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.19%. Humana’s dividend payout ratio is presently 31.36%.

Wall Street Analyst Weigh In

HUM has been the topic of several research analyst reports. KeyCorp started coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. TD Cowen upped their target price on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. lifted their price target on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Truist Financial decreased their price objective on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Finally, Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus price target of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.